Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (61-70 of 717) with videos related to

Pageof 72
Sort By:
Lancet (London, England)|October 10, 2022
Xanthine oxidase inhibition for cardiovascular disease preventionAtsushi Tanaka, Koichi Node
Journal of the American College of Cardiology|October 8, 2021
What Is Behind the HbA1c Value?Atsushi Tanaka, Koichi Node
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 8, 2009
[Vascular endothelial dysfunction]Noriko Ide, Koichi Node
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2010
[Effects of PPARgamma agonist on dyslipidemia and atherosclerosis]Aiko Komatsu, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2010
Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failureHiroaki Kawano, Koichi Node
Diabetology International|August 18, 2020
Promising roles of sodium-glucose cotransporter 2 inhibitors in heart failure prevention and treatmentAtsushi Tanaka, Koichi Node
Circulation Journal : Official Journal of the Japanese Circulation Society|April 14, 2015
Glycemic variability and cardiac remodeling in patients with acute myocardial infarctionMasahiro Natsuaki, Koichi Node
The Lancet. Diabetes & Endocrinology|April 17, 2021
Fluid volume regulation in patients with heart failureAtsushi Tanaka, Koichi Node
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2012
[Basic efficiently of drug eluting stent 2011]Yutaka Hikichi, Koichi Node
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Letter by Tanaka and Node Regarding Article, "Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study"Atsushi Tanaka, Koichi Node
Pageof 72

Showing results (61-70 of 717) with videos related to

Sort By:
Pageof 72
Lancet (London, England)|October 10, 2022
Xanthine oxidase inhibition for cardiovascular disease preventionAtsushi Tanaka, Koichi Node
Journal of the American College of Cardiology|October 8, 2021
What Is Behind the HbA1c Value?Atsushi Tanaka, Koichi Node
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 8, 2009
[Vascular endothelial dysfunction]Noriko Ide, Koichi Node
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2010
[Effects of PPARgamma agonist on dyslipidemia and atherosclerosis]Aiko Komatsu, Koichi Node
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2010
Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failureHiroaki Kawano, Koichi Node
Diabetology International|August 18, 2020
Promising roles of sodium-glucose cotransporter 2 inhibitors in heart failure prevention and treatmentAtsushi Tanaka, Koichi Node
Circulation Journal : Official Journal of the Japanese Circulation Society|April 14, 2015
Glycemic variability and cardiac remodeling in patients with acute myocardial infarctionMasahiro Natsuaki, Koichi Node
The Lancet. Diabetes & Endocrinology|April 17, 2021
Fluid volume regulation in patients with heart failureAtsushi Tanaka, Koichi Node
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2012
[Basic efficiently of drug eluting stent 2011]Yutaka Hikichi, Koichi Node
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Letter by Tanaka and Node Regarding Article, "Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study"Atsushi Tanaka, Koichi Node
Pageof 72